Randomized Controlled Trial Comparing Residual Renal Function in Patients Undergoing Three or Four Exchanges CAPD
This study has been completed.
Sponsor:
Shanghai Jiao Tong University School of Medicine
Information provided by (Responsible Party):
Aiwu Lin, Shanghai Jiao Tong University School of Medicine
ClinicalTrials.gov Identifier:
NCT01637792
First received: July 1, 2012
Last updated: July 8, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study was to explore the impacts of different continuous ambulatory peritoneal dialysis (CAPD) dosage (three 2-Liter exchanges CAPD vs. four 2-Liter exchanges CAPD) on residual renal function, technique survival and peritonitis rate in incident Chinese peritoneal dialysis patients.
| Condition | Intervention | Phase |
|---|---|---|
|
End Stage Renal Disease Anuria Peritonitis |
Other: Three 2-liter exchanges daily CAPD |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Randomized Controlled Trial Comparing Residual Renal Function in Patients Undergoing Three or Four Exchanges CAPD |
Resource links provided by NLM:
Further study details as provided by Shanghai Jiao Tong University School of Medicine:
Primary Outcome Measures:
- The changes in residual renal function including urine volume and residual glomerular filtration rate. [ Time Frame: Month 1 and 24 after CAPD initiation ] [ Designated as safety issue: No ]
- Number of participants developing to anuria (permanently daily urine volume less than 200ml) [ Time Frame: Up to 24 months after CAPD initiation ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Number of participants having technique failure including death and switching to maintenance hemodialyisis [ Time Frame: Up to 24 months after CAPD initiation. ] [ Designated as safety issue: Yes ]
- Episodes of peritonitis [ Time Frame: Up to 24 months after CAPD initiation ] [ Designated as safety issue: Yes ]
| Enrollment: | 131 |
| Study Start Date: | June 2004 |
| Study Completion Date: | August 2010 |
| Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Three 2-liter exchanges group
A group of randomly assigned patients undergoing three 2-liter exchanges daily CAPD.
|
Other: Three 2-liter exchanges daily CAPD
CAPD regimen of three 2-liter daily exchanges
Other Name: small volume CAPD
|
|
Active Comparator: Four 2-liter exchanges group
A group of randomly assigned patients undergoing four 2-liter exchanges daily CAPD.
|
Other: Three 2-liter exchanges daily CAPD
CAPD regimen of three 2-liter daily exchanges
Other Name: small volume CAPD
|
Detailed Description:
- The primary end point for this study was changes in RRF including 24-h urine volume and residual GFR. These were evaluated at month 1, which was defined as the baseline, and then at month 6, 12, 18 and 24. At the same time, body weight, blood pressure, daily net ultrafiltration, and dialysis adequacy were assessed. Once an episode of peritonitis or other serious reversible intercurrent illness occurred, all the assessments were delayed one month after being cured. Anuria was termed by daily Uvol permanently less than 200 ml.
- The secondary end points included technique survival and peritonitis rate. Technique failure was defined as both death and switch to maintenance hemodialysis.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- incident peritoneal dialysis patients
- age between 18 to 80 yrs
Exclusion Criteria:
- have a history of maintenance hemodialysis or renal transplantation
- daily urine volume less than 800 ml
- in severe conditions
- unable to give informed consent
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01637792
Locations
| China, Shanghai | |
| Renji Hospital, Shanghai Jiao Tong University school of medicine | |
| Shanghai, Shanghai, China, 200127 | |
Sponsors and Collaborators
Shanghai Jiao Tong University School of Medicine
Investigators
| Principal Investigator: | Wei Fang, MD, PhD | Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine |
More Information
Publications:
| Responsible Party: | Aiwu Lin, MD, PhD, Shanghai Jiao Tong University School of Medicine |
| ClinicalTrials.gov Identifier: | NCT01637792 History of Changes |
| Other Study ID Numbers: | 044119620, 07QA14040, 08DZ1900501 |
| Study First Received: | July 1, 2012 |
| Last Updated: | July 8, 2012 |
| Health Authority: | China: Science and Technology Commission of Shanghai Municipality |
Keywords provided by Shanghai Jiao Tong University School of Medicine:
|
peritoneal dialysis dose residual renal function technique survival peritonitis |
Additional relevant MeSH terms:
|
Anuria Kidney Diseases Kidney Failure, Chronic Peritonitis Urologic Diseases |
Urination Disorders Renal Insufficiency, Chronic Renal Insufficiency Peritoneal Diseases Digestive System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013